Lotus Mallbris

7.6k citations
96 papers · 4.8k indexed · 2 hit papers · h-index 40
Topics
Psoriasis: Treatment and Pathogenesis (75 papers)Dermatology and Skin Diseases (40 papers)Asthma and respiratory diseases (17 papers)

In The Last Decade

Lotus Mallbris

94 papers receiving 4.7k citations

Hit Papers

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque...201620262019202220162016200400600

Peers

Lotus Mallbris
Comparison fields: 5 of 110
  • Immunology 3.5k
  • Dermatology 2.1k
  • Rheumatology 1.2k
  • Physiology 739
  • Pathology and Forensic Medicine 631
Replace A. David Burden with:
A. David Burden United Kingdom
Yves Poulin Canada
Lisa T. Dooley United States
C. Papavassilis Germany
E. Daudén Spain
Joseph F. Merola United States
Wayne Gulliver Canada
Jerry Bagel United States
Peter van de Kerkhof Netherlands
Sascha Gerdes Germany
Lotus Mallbris relative to A. David Burden United Kingdom A. David Burden's profile →
Citations per field
00.5×1.5×1.9×
A. David Burden · 1×
Citations per year

Countries citing papers authored by Lotus Mallbris

Since Specialization
Citations

This map shows the geographic impact of Lotus Mallbris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotus Mallbris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotus Mallbris more than expected).

Fields of papers citing papers by Lotus Mallbris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lotus Mallbris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotus Mallbris. The network helps show where Lotus Mallbris may publish in the future.

Co-authorship network of co-authors of Lotus Mallbris

This figure shows the co-authorship network connecting the top 25 collaborators of Lotus Mallbris. A scholar is included among the top collaborators of Lotus Mallbris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lotus Mallbris. Lotus Mallbris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 9
3
Ixekizumab Provides Sustained Improvement In Signs And Symptoms In Patients With Active Psoriatic Arthritis: Two Year Results From A Phase 3 Trial
1
4 51
5 77
6 2
7 57
8
Topical tofacitinib for atopic dermatitis: a phase II a randomized trialbreakdown →
320
9 35
10 8
11 48
12 6
13 1
14 21
15 18
16 1
17 43
18 57
19 11
20 87

About Lotus Mallbris

Lotus Mallbris is a scholar working on Dermatology, Immunology and Immunology and Allergy, having authored 96 papers that have together received 4.8k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (75 papers), Dermatology and Skin Diseases (40 papers) and Asthma and respiratory diseases (17 papers). The work is most often cited by research in Dermatology (2.1k citations), Immunology (3.5k citations) and Rheumatology (1.2k citations). Lotus Mallbris has collaborated with scholars based in United States, Sweden and Denmark. Frequent co-authors include Mona Ståhle, Alexander Egeberg, Fredrik Granath, Gunnar Gislason, Lone Skov, Kim Papp, Peter Riis Hansen, Anders Hamsten, Mona Ståhle‐Bäckdahl and Kristian Reich. Their work appears in journals such as New England Journal of Medicine, Annals of the Rheumatic Diseases and Journal of Investigative Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026